We are live on ! Find out more
ANIX icon

Anixa Biosciences

59 hedge funds and large institutions have $16M invested in Anixa Biosciences in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more call options, than puts

Call options by funds: $122K | Put options by funds: $71K

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

4% more funds holding

Funds holding: 57 → 59 (+2)

0.73% less ownership

Funds ownership: 18.15% → 17.42% (-0.73%)

50% less capital inflows, than outflows

Capital inflows: $568K | Capital outflows: $1.13M

Holders
59
Holders Change
+2
Holders Change %
+3.51%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
11
Reduced
7
Closed
7
Calls
$122K
Puts
$71K
Net Calls
+$51K
Net Calls Change
-$88K

ANIX Hedge Fund Activity: Q1 2025 in Review

59 of the 7,491 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q1 2025, worth a combined $16M — up 18% from $13.6M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ANIX positions and 7 closed out — a net gain of 2 holders — while 11 added to existing stakes and 7 trimmed.

The largest buyer was GSA Capital Partners, opening a new position worth an estimated $217K. The largest seller was Long Focus Capital Management, exiting entirely with an estimated $342K sold.

  • 59 institutional investors held Anixa Biosciences (ANIX) as of Q1 2025, up from 57 in Q4 2024.
  • Funds reported $16M of Anixa Biosciences stock for Q1 2025, up 18% quarter-over-quarter.
  • 9 funds opened new Anixa Biosciences positions in Q1 2025 and 7 closed out, a net change of +2 holders.
  • The largest Anixa Biosciences buyer in Q1 2025 was GSA Capital Partners, an estimated $217K added.
  • The largest Anixa Biosciences seller in Q1 2025 was Long Focus Capital Management, an estimated $342K sold.

Based on aggregated 13F filings for Q1 2025.